Author

Nancy Le Cam

Observed names: Le Cam N, N. Bouveret-Le Cam, N.N. Bouveret Le Cam (xc*), Nancy B. Le Cam, Nancy Bouveret, Nancy Bouveret Le Cam, Nancy Bouveret-Le Cam, Nancy Bouveret-le-Cam, Nancy Bouveret-le-cam, Nancy Bouveret‐le‐Cam, Nancy Le Cam Bouveret, Nancy N Bouveret le Cam, Nancy N. Le Cam

Institution: Moderna Therapeutics (United States)

Observed institutions: University of the Witwatersrand, Takeda (Switzerland), Moderna Therapeutics (United States), GlaxoSmithKline (Canada), Center of Immunology Pierre Fabre, Variation Biotechnologies (Canada), South African Institute for Medical Research

OpenAlex ID: A5041305080

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

1996 · Keith P. Klugman, Hendrik J. Koornhof, et al. · Vaccine · 219

The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

2023 · Brandon Essink, Laurence Chu, et al. · The Lancet Infectious Diseases · 150

Safety and Immunogenicity of a Novel Recombinant Subunit Respiratory Syncytial Virus Vaccine (BBG2Na) in Healthy Young Adults

2001 · Ultan F. Power, Thien N. Nguyen, et al. · The Journal of Infectious Diseases · 119

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

2010 · Lisa A Jackson, Manjusha J Gaglani, et al. · BMC Infectious Diseases · 103

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers

2003 · Joëlle Bruge, Nancy Bouveret-Le Cam, et al. · Vaccine · 93

Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial

2014 · Linda McAllister, Jonathan Anderson, et al. · The Lancet · 89

Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa

2008 · Che-Hung Lee, Wen-Chun Kuo, et al. · Vaccine · 74

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults

2024 · Jaya Goswami, Abdullah H Baqui, et al. · The Journal of Infectious Diseases · 46

Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization

1999 · Karen H Keddy, Keith P Klugman, et al. · Vaccine · 45

A vaccine manufacturer’s approach to address medical needs related to seasonal and pandemic influenza viruses

2008 · Benoit Baras, Nancy Bouveret, et al. · Influenza and Other Respiratory Viruses · 43

A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose

2020 · John Treanor, Jim Sherwood, et al. · Vaccine · 35

Adjuvants for influenza vaccine

1998 · N.N. Bouveret Le Cam (xc*), J. Ronco, et al. · Research in Immunology · 33

Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial

2025 · Chong Ma, Jiejun Du, et al. · Nature Communications · 27

Passive Transfer of Serum Antibodies Induced by BBG2Na, a Subunit Vaccine, in the Elderly Protects SCID Mouse Lungs Against Respiratory Syncytial Virus Challenge

2002 · Hélène Plotnicky-Gilquin, Dominique Cyblat-Chanal, et al. · Virology · 17

Bivalent Norovirus VLP Vaccine Candidate in Older Adults: Impact of MPL and a Second Dose in a Randomized, Controlled, Double-Blind Clinical Trial

2017 · Jim Sherwood, Jakob Cramer, et al. · Open Forum Infectious Diseases

Present and future directions for a Vi polysaccharide vaccine in preventing Typhoid fever

1998 · R. Dumas, D. Chassard, et al. · Medical Journal of Indonesia

Long term serological response to Vi vaccine and protective immunity

1998 · Keith P. Klugman, Karin Keddy, et al. · Medical Journal of Indonesia

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults

· Goswami J, Baqui AH, et al. · Newcastle University ePrints (Newcastle Univesity)

Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial

· Ma C, Du J, et al. · Newcastle University ePrints (Newcastle Univesity)

Works count: 21

Citation count: 1,093

H-index: 14

I10-index: 14